Understanding Low Gynecological Cancer Delay and Help-seeking Behavior in Older Patients.
CODEGY65
1 other identifier
observational
12
1 country
1
Brief Summary
Systematic screening for cervical cancer stops in France at 65 years old. The incidence of certain types of gynecological neoplasia increases with age (endometrium, vulva). Diagnosis delay of 8 months has been described for uterine cancer and longer delays for vulvar cancer. The aim of our study is to understand help-seeking behavior and its delay for this type of cancer among patients older than 65.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 19, 2017
CompletedStudy Start
First participant enrolled
October 30, 2017
CompletedFirst Posted
Study publicly available on registry
November 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 12, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 27, 2018
CompletedAugust 8, 2018
August 1, 2018
4 months
October 19, 2017
August 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Experience of help-seeking period for low gynecological cancers.
Qualitative interview performed at one occasion where the patient describes the experience of the help seeking period she has passed through.
1 day
Secondary Outcomes (1)
Motivators and barriers to help-seeking for low gynecological cancers.
1 day
Interventions
Patients will be interviewed by open-ended questions face to face concerning their past experiences. The recorded interview will be transcribed and analyzed by psychodynamic and semio-pragmatic approach.
Eligibility Criteria
Women of 65 years or more treated or followed at Lorraine Institute of Oncology Diagnosed after 65 years or later of a low gynecological cancer
You may qualify if:
- Women of 65 years or more treated or followed at Lorraine Institute of Oncology
- Diagnosed after 65 years or later of a low gynecological cancer
- Without diagnosis of dementia
- Retained ability to express by herself without assistance
- Affiliated to public health system
- Informed and having expressed her non-opposition
You may not qualify if:
- Women under 65 or diagnosed before being 65 of a low gynecological cancer
- Diagnosed of dementia
- No longer to express herself
- Patient deprived of freedom
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institut de Cancérologie de Lorraine (ICL)
Vandœuvre-lès-Nancy, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
MARCHAL FREDERIC, MD
Institut de Cancérologie de Lorraine
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 19, 2017
First Posted
November 8, 2017
Study Start
October 30, 2017
Primary Completion
March 12, 2018
Study Completion
July 27, 2018
Last Updated
August 8, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share